Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
$17.18
-2.8%
$16.37
$2.80
$8.97
$619.48M0.6337,931 shs1.18 million shs
TRX Gold Co. stock logo
TRX
TRX Gold
$0.35
-0.7%
$0.34
$0.27
$0.43
$99.28M0.23489,661 shs322,339 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
-2.83%-3.86%+2.57%+18.81%+58.05%
TRX Gold Co. stock logo
TRX
TRX Gold
0.00%-3.88%+3.99%+15.50%-17.77%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
TRX Gold Co. stock logo
TRX
TRX Gold
2.1693 of 5 stars
3.50.00.00.01.10.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
0.00
N/AN/AN/A
TRX Gold Co. stock logo
TRX
TRX Gold
3.00
Buy$1.10214.83% Upside

Current Analyst Ratings Breakdown

Latest IXI, FUM, SBTX, and TRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
TRX Gold Co. stock logo
TRX
TRX Gold
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$1.00 ➝ $1.10
(Data available from 8/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
N/AN/AN/AN/A$7.41 per shareN/A
TRX Gold Co. stock logo
TRX
TRX Gold
$47.73M2.08$0.00 per share173.35$0.24 per share1.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
-$89.48M-$2.42N/AN/AN/A-29.62%-28.20%N/A
TRX Gold Co. stock logo
TRX
TRX Gold
-$470KN/AN/A5.82N/A6.11%2.21%1.51%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
N/AN/AN/AN/AN/A
TRX Gold Co. stock logo
TRX
TRX Gold
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
N/A
67.87
67.87
TRX Gold Co. stock logo
TRX
TRX Gold
0.03
0.83
0.51

Institutional Ownership

CompanyInstitutional Ownership
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
74.89%
TRX Gold Co. stock logo
TRX
TRX Gold
1.06%

Insider Ownership

CompanyInsider Ownership
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
34.40%
TRX Gold Co. stock logo
TRX
TRX Gold
2.25%
CompanyEmployeesShares OutstandingFree FloatOptionable
Silverback Therapeutics, Inc. stock logo
SBTX
Silverback Therapeutics
8336.06 million23.65 millionNot Optionable
TRX Gold Co. stock logo
TRX
TRX Gold
120284.15 million275.50 millionOptionable

Recent News About These Companies

TRX Gold Q3 2025 Earnings Preview
TRX Gold (NYSE:TRX) Price Target Raised to $1.10
TRX Gold Reports Third Quarter 2025 Results
Buckreef signs gold sale with BoT
TRX Gold Buckreef PEA: Mining Metals, Not Investors

New MarketBeat Followers Over Time

Media Sentiment Over Time

Silverback Therapeutics stock logo

Silverback Therapeutics NASDAQ:SBTX

$17.18 -0.50 (-2.83%)
As of 08/1/2025

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

TRX Gold stock logo

TRX Gold NYSE:TRX

$0.35 0.00 (-0.74%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$0.34 0.00 (-1.26%)
As of 08/1/2025 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TRX Gold Corporation engages in the exploration, development, and production of mineral property interests in the United Republic of Tanzania. The company primarily explores for gold deposits. It holds interests in the Buckreef gold project that comprises a single Special Mining License covering an area of 16.04 square kilometers and 12 Prospecting Licenses covering 98.19 square kilometers located in north-central Tanzania. The company was formerly known as Tanzanian Gold Corporation and changed its name to TRX Gold Corporation in May 2022. TRX Gold Corporation was incorporated in 1990 and is based in Oakville, Canada.